Your session is about to expire
← Back to Search
Nutrition Algorithm
Nutrition Algorithm for Cancer
N/A
Waitlist Available
Led By Marilyn Hammer, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial seeks to develop a nutrition algorithm to improve quality of life for cancer patients. It will use a technology-based platform to help track nutrition and health outcomes.
Who is the study for?
This trial is for dietitians and oncology clinicians who have worked with at least three patients facing nutritional challenges, members of a Patient and Family Advisory Council (PFAC) over 18 years old, and cancer patients who've finished or are undergoing treatment. Participants must speak English and have access to a device like a computer or smartphone.Check my eligibility
What is being tested?
The study is testing the 'Nutrition Algorithm for Cancer Health Outcomes' (NACHO), which is a technology-based platform designed to improve nutrition and quality of life in people recovering from or currently receiving cancer treatment.See study design
What are the potential side effects?
Since this intervention involves nutritional guidance rather than medication, there may not be direct side effects like those associated with drugs. However, changes in diet can sometimes lead to digestive adjustments or food sensitivities.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Nutrition Algorithm
Secondary outcome measures
Acceptability of Nutrition Algorithm for Cancer Health Outcomes (NACHO) Program
Characteristics of the cohort of 100 patients (Aim 3) - Age
Characteristics of the cohort of 100 patients (Aim 3) - BMI
+12 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Nutrition Algorithm (NACHO)Experimental Treatment1 Intervention
Study procedures will be conducted as follows:
Development of nutrition algorithm by dietitian panel participants with oncology clinician consultation via convened group meetings.
Refinement of draft algorithms through feedback from participants and Family Advisory Council (PFAC) members.
Baseline questionnaires for participants.
Semi-structured interviews and/or focus groups with participants to evaluate algorithm usability and acceptability.
Participant questionnaires.
Find a Location
Who is running the clinical trial?
Cancer Nutrition Consortium Inc.UNKNOWN
Dana-Farber Cancer InstituteLead Sponsor
1,079 Previous Clinical Trials
340,818 Total Patients Enrolled
Marilyn Hammer, MDPrincipal InvestigatorDana-Farber Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My doctor does not recommend I participate.I am over 18 and a current member of the adult Patient and Family Advisory Council.
Research Study Groups:
This trial has the following groups:- Group 1: Nutrition Algorithm (NACHO)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this research project still available?
"Clinicaltrials.gov reveals that this particular investigation is not currently enrolling participants; initially posted on August 1st 2023 and last updated April 21st 2023, however there are 389 alternative studies actively recruiting patients."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger